Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.63 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | ACR | P10323 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10708455 | 0.92 | KIF11 (0.56) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL10706859 | 0.90 | KIF11 (0.54) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL10706875 | 0.90 | KIF11 (0.54) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL697018 | 0.88 | KIF11 (0.56) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL697017 | 0.88 | KIF11 (0.56) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL10706993 | 0.87 | KIF11 (0.51) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL10710562 | 0.86 | KIF11 (0.58) | KIF11PRSS1ACRALDH1A1EPHX2 | |
| SCHEMBL12704880 | 0.84 | KIF11 (0.61) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL15453601 | 0.84 | KIF11 (0.61) | KIF11CES2CES1PRSS1ACR | |
| SCHEMBL21991236 | 0.83 | KIF11 (0.51) | KIF11CES2CES1PRSS1ACR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2406257-B1 | A NEW METHOD FOR THE PREPARATION OF SOLIFENACIN AND NEW INTERMEDIATE THEREOF | MEGAFINE PHARMA P LTD (IN) | 2019-08-07 | — | — | EP | claimed |
| US-8283470-B2 | Method for the preparation of solifenacin and intermediate thereof | MEGAFINE PHARMA(P) LTD. (IN) | 2012-10-09 | — | — | US | claimed |
| EP-2406257-A1 | A NEW METHOD FOR THE PREPARATION OF SOLIFENACIN AND NEW INTERMEDIATE THEREOF | Megafine Pharma (P) Ltd. (IN) | 2012-01-18 | — | — | EP | claimed |
| US-20110319621-A1 | METHOD FOR THE PREPARATION OF SOLIFENACIN AND INTERMEDIATE THEREOF | MEGAFINE PHARMA(P) LTD. (IN) | 2011-12-29 | — | — | US | claimed |
| WO-2010103529-A1 | A NEW METHOD FOR THE PREPARATION OF SOLIFENACIN AND NEW INTERMEDIATE THEREOF | MEGAFINE PHARMA(P) LTD. (IN) | 2010-09-16 | — | — | WO | claimed |
| EP-1504048-B1 | METHOD OF PREPARING POLYESTERCARBONATES | GEN ELECTRIC (US) | 2007-11-21 | — | — | EP | claimed |
| EP-1504048-A1 | METHOD OF PREPARING POLYESTERCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2005-02-09 | — | — | EP | claimed |
| WO-2003087190-A1 | METHOD OF PREPARING POLYESTERCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2003-10-23 | — | — | WO | claimed |
| US-6600004-B1 | Preparing polyestercarbonates is presented in which a mixture of at least one activated diaryl carbonate is reacted under melt polymerization conditions with at least one aromatic dihydroxy compound together with at least one dicarboxylic | GENERAL ELECTRIC COMPANY | 2003-07-29 | — | — | US | claimed |
| JP-59001444-A | — | — | None | — | — | JP | disclosed |
| JP-59013749-A | — | — | None | — | — | JP | disclosed |
| WO-2025121420-A1 | POLYCARBONATE AND METHOD FOR PRODUCING THE SAME | ＡＧＣ株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-20240117113-A1 | METHOD FOR PRODUCING POLYCARBONATE | AGC Inc. (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4342928-A1 | METHOD FOR PRODUCING POLYCARBONATE | AGC INC. (JP) | 2024-03-27 | — | — | EP | disclosed |
| US-6600004-B1 | Preparing polyestercarbonates is presented in which a mixture of at least one activated diaryl carbonate is reacted under melt polymerization conditions with at least one aromatic dihydroxy compound together with at least one dicarboxylic | GENERAL ELECTRIC COMPANY | 2003-07-29 | — | — | US | disclosed |
| EP-0837085-A1 | POLYCARBONATE-BASE POLYMER, PRODUCTION PROCESS, RESIN COATING FLUID PREPARED THEREFROM, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-04-22 | — | — | EP | disclosed |
| EP-0184012-B1 | LIQUID CRYSTAL COMPOSITIONS | BAYER AG (DE) | 1988-01-07 | — | — | EP | disclosed |
| EP-0184012-A1 | Liquid crystal compositions | BAYER AG (DE) | 1986-06-11 | — | — | EP | disclosed |
| JP-S5913749-A | PREPARATION OF 4-TRIFLUOROMETHYL-4'-NITRODIPHENYL ETHER COMPOUND | HODOGAYA CHEM CO LTD | 1984-01-24 | — | — | JP | disclosed |
| JP-S591444-A | PREPARATION OF BIS(2-CHLORO-4-TRIFLUOROMETHYLPHENYL) CARBONATE | HODOGAYA CHEM CO LTD | 1984-01-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319621-A1 | METHOD FOR THE PREPARATION OF SOLIFENACIN AND INTERMEDIATE THEREOF | CHRM3, CHRNA1, ADRA1A | KIF11 4272/4885CES2 3122/4885CES1 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.